Bristol Myers Squibb and Pfizer are offering an insurance-free pathway to access one of their widely used blood thinners. The pharmaceutical giants launched a new direct-to-patient option for purchasing Eliquis, the brand name for apixaban, through its Alliance’s patient resource Eliquis 360 Support, in an effort to expand patient access. Starting Sept. 8, eligible U.S. patients that are uninsured, underinsured or seek to pay out-of-pocket, can get the Eliquis prescription at a 40% discount. This means those patients will pay $346 a month in cash instead of the $606 list price.The program will...

5 hours ago

On HALO